↓ Skip to main content

Dove Medical Press

Quantifying the treatment goals of people recently diagnosed with schizophrenia using best–worst scaling

Overview of attention for article published in Patient preference and adherence, January 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
68 Mendeley
Title
Quantifying the treatment goals of people recently diagnosed with schizophrenia using best–worst scaling
Published in
Patient preference and adherence, January 2018
DOI 10.2147/ppa.s152870
Pubmed ID
Authors

John FP Bridges, Kathleen Beusterien, Stephan Heres, Pedro Such, Joaquín Sánchez-Covisa, Anna-Greta Nylander, Elcie Chan, Anne de Jong-Laird

Abstract

This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan. People aged 18-35 years with a confirmed diagnosis of schizophrenia within the past 5 years were surveyed in the UK, Germany, and Italy. Treatment goals were assessed via a validated best-worst scaling instrument, where participants evaluated subsets of 13 possible treatment goals identified using a balanced incomplete block design. Participants identified the most and least important goals within each task. Data were also collected on current treatment and preference for daily oral versus long-acting injectable (LAI) treatment. Hierarchical Bayes was used to identify preference weights for the goals, and latent class analysis was used to identify segments of people with similar goals. The segments were compared with the current treatment and preference for oral versus LAI treatment. Across 100 participants, the average age was 26 years, 75% were male and 50% were diagnosed within 2 years ago. Overall, preferences were most favorable for reduced disease symptoms, think clearly, reduced hospitalizations, reduced anxiety, and take care of self. A total of 61% preferred oral medication and 39% LAI. Two groups were identified with different treatment goals; 50% of participants emphasized clinical goals, including reduced disease symptoms (preference weight =19.7%), reduced hospitalizations (15.5%), and reduced anxiety (10.5%). The other 50% emphasized functional goals, including improved relationships with family/friends (11.4%), increased interest in work (10.6%), experiencing a fuller range of emotions (8.4%), and ability to socialize (7.5%). Those emphasizing functional goals were more likely to be on LAI (44% versus 26%; p=0.059) and preferred LAI (46% versus 32%; p=0.151). People with recent-onset schizophrenia may focus more on clinical goals or functional goals, a discussion of which may help facilitate patient engagement.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 13%
Researcher 8 12%
Other 7 10%
Student > Doctoral Student 5 7%
Student > Master 4 6%
Other 14 21%
Unknown 21 31%
Readers by discipline Count As %
Psychology 8 12%
Nursing and Health Professions 7 10%
Medicine and Dentistry 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Social Sciences 4 6%
Other 12 18%
Unknown 25 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2023.
All research outputs
#16,188,873
of 25,584,565 outputs
Outputs from Patient preference and adherence
#904
of 1,733 outputs
Outputs of similar age
#256,430
of 450,901 outputs
Outputs of similar age from Patient preference and adherence
#19
of 32 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,733 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.